| ICD Code | Description |
|---|---|
| M310 | Hypersensitivity angiitis |
| M311 | Thrombotic microangiopathy |
| M312 | Lethal midline granuloma |
| M313 | Wegener's granulomatosis |
| M314 | Aortic arch syndrome [Takayasu] |
| M315 | Giant cell arteritis with polymyalgia rheumatica |
| M316 | Other giant cell arteritis |
| M317 | Microscopic polyangiitis |
| M318 | Other specified necrotizing vasculopathies |
| M319 | Necrotizing vasculopathy, unspecified |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M316 | Other giant cell arteritis | 14.19 | |||||||||||||
| M311 | Thrombotic microangiopathy | 18.19 | |||||||||||||
| M310 | Hypersensitivity angiitis | 24.76 | |||||||||||||
| M315 | Giant cell arteritis with polymyalgia rheumatica | 12.18 | |||||||||||||
| M317 | Microscopic polyangiitis | 17.03 | |||||||||||||
| M318 | Other specified necrotizing vasculopathies | 21.05 | |||||||||||||
| M314 | Aortic arch syndrome [Takayasu] | 16.67 | |||||||||||||
| M319 | Necrotizing vasculopathy, unspecified | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M316 | Other giant cell arteritis | 5.47 | 23.78 | ||||||||||||||||
| M310 | Hypersensitivity angiitis | 8.67 | 35.83 | ||||||||||||||||
| M311 | Thrombotic microangiopathy | 11.25 | 33.69 | ||||||||||||||||
| M315 | Giant cell arteritis with polymyalgia rheumatica | 5.53 | 23.62 | ||||||||||||||||
| M317 | Microscopic polyangiitis | 9.24 | 32.13 | ||||||||||||||||
| M319 | Necrotizing vasculopathy, unspecified | 8.99 | 32.56 | ||||||||||||||||
| M318 | Other specified necrotizing vasculopathies | 10.71 | 36.46 | ||||||||||||||||
| M314 | Aortic arch syndrome [Takayasu] | 5.98 | 24.36 | ||||||||||||||||
| M312 | Lethal midline granuloma | 5.27 | NA |